Trending

24/7 Market News (NASDAQ: AVRO) AVROBIO INC. has received news this morning that has shares up more than 10% on 1100 plus trades and light volume.

The company is trading at $1.08 and looks to improve on FDA granting orphan drug designation.

AVROBIO Receives Orphan Drug Designation from the U.S. Food and Drug Administration for AVR-RD-05, a Gene Therapy for Mucopolysaccharidosis Type II (MPSII) or Hunter Syndrome

https://finance.yahoo.com/news/avrobio-receives-orphan-drug-designation-110000405.html

RelatedNews

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist